European distribution partnership between NeuroproteXeon and Linde
NeuroproteXeon have completed a distribution agreement with Linde AG for XENEXTM (xenon by inhalation) for Post Cardiac Arrest Syndrome (PCAS) for the European Union plus United Kingdom, Switzerland, Norway and Iceland.